ING Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.1M	Buy	+90,000	New	+$25.9M	0.15%	113
2024 Q2	–	Sell	-2,868	Closed	-$992K	–	547
2024 Q1	$992K	Sell	2,868 -3,598	-56%	-$1.18M	0.01%	514
2023 Q4	$2.09M	Buy	6,466 +6,344	+5,200%	+$1.99M	0.02%	400
2023 Q3	$43.7K	Buy	+122	New	+$47.1K	﹤0.01%	552
2023 Q2	–	Sell	-3,659	Closed	-$1.75M	–	552
2023 Q1	$1.75M	Sell	3,659 -2	-0.1%	-$936	0.02%	379
2022 Q4	$1.54M	Buy	+3,661	New	+$1.48M	0.02%	387
2022 Q3	–	Sell	-1,873	Closed	-$927K	–	418
2022 Q2	$927K	Sell	1,873 -1,555	-45%	-$810K	0.01%	459
2022 Q1	$1.93M	Sell	3,428 -4,092	-54%	-$2.47M	0.02%	400
2021 Q4	$5.68M	Buy	7,520 +1,016	+16%	+$760K	0.05%	253
2021 Q3	$4.85M	Buy	6,504 +4,734	+267%	+$3.55M	0.06%	200
2021 Q2	$1.14M	Buy	1,770 +343	+24%	+$209K	0.02%	425
2021 Q1	$815K	Sell	1,427 -1	-0.1%	-$592	0.02%	426
2020 Q4	$832K	Buy	1,428 +955	+202%	+$544K	0.02%	435
2020 Q3	$244K	Buy	+473	New	+$240K	0.01%	444
2018 Q4	–	Sell	-3,063	Closed	-$959K	–	707
2018 Q3	$959K	Sell	3,063 -39	-1%	-$12.1K	0.02%	372
2018 Q2	$895K	Buy	+3,102	New	+$857K	0.02%	341
2018 Q1	–	Sell	-2,310	Closed	-$551K	–	736
2017 Q4	$551K	Buy	2,310 +587	+34%	+$142K	0.01%	477
2017 Q3	$383K	Sell	1,723 -809	-32%	-$182K	0.01%	601
2017 Q2	$573K	Buy	+2,532	New	+$552K	0.01%	442